NCT00808262View on ClinicalTrials.gov

Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Crohn's Disease
Interventions
BIOLOGICAL

TNFa Kinoid

TNFa kinoid at days 0, 7, 28

Trial Locations (6)

7550

Durbanville Medi-Clinic, Cape Town

Unknown

Parexel Port Elizabeth, Port Elizabeth

Farmovs Parexel, Bloemfontein

Parexel George, George

Centre Hospitalier Universitaire Vaudois, Lausanne

Universitätsspital Zürich, Zurich

Sponsors

Lead Sponsor

Neovacs
All Listed Sponsors
lead

Neovacs

INDUSTRY

NCT00808262 - Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease | Biotech Hunter | Biotech Hunter